{ "docId": "019dd923-5fec-763b-95d0-6c2b37f81466", "docSlug": "bi-9523b367be63361f", "documentTitle": "3T Biosciences 27-slide pitch deck to raise $40M Series A", "authorId": "Pitchdecks", "authorName": "3T Biosciences", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.6, "pageNumber": 5, "pageCount": 27, "prevPage": 4, "nextPage": 6, "slideType": "team_bio", "function": "other", "density": "overcrowded", "nDataPoints": 0, "notes": null, "elementsJson": [ "headline_text", "action_title", "headshot", "bullet_list" ], "metadataConfidence": 1, "imagePath": null, "slideHref": "/slides/019dd923-5fec-763b-95d0-6c2b37f81466/5", "deckHref": "/decks/019dd923-5fec-763b-95d0-6c2b37f81466", "deckJsonHref": "/decks/019dd923-5fec-763b-95d0-6c2b37f81466.json", "deckAnchorHref": "/decks/019dd923-5fec-763b-95d0-6c2b37f81466#slide-5", "components": [ { "bbox": { "h": 0.18, "w": 0.14, "x": 0.04, "y": 0.192 }, "kind": "image", "text": null, "attrs": null, "subkind": "headshot", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "00024b96-844a-4f05-974f-245cf3a4e86b", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.18, "w": 0.14, "x": 0.04, "y": 0.605 }, "kind": "image", "text": null, "attrs": null, "subkind": "headshot", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "0b6d3cde-7439-48ee-a96d-0d0fd66f6867", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.18, "w": 0.14, "x": 0.04, "y": 0.392 }, "kind": "image", "text": null, "attrs": null, "subkind": "headshot", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "3410b6e5-56f7-4354-a210-f5bdb28c53aa", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.18, "w": 0.14, "x": 0.523, "y": 0.192 }, "kind": "image", "text": null, "attrs": null, "subkind": "headshot", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "48d853e6-de46-47d8-a7b6-e7a2a691e67c", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.18, "w": 0.14, "x": 0.523, "y": 0.812 }, "kind": "image", "text": null, "attrs": null, "subkind": "headshot", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "4ee38cfc-c7e9-45e8-87d5-72da414f4d4f", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.18, "w": 0.14, "x": 0.523, "y": 0.605 }, "kind": "image", "text": null, "attrs": null, "subkind": "headshot", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "857c52e3-d22e-44f9-b49c-9c3ad932b9bb", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.18, "w": 0.14, "x": 0.523, "y": 0.392 }, "kind": "image", "text": null, "attrs": null, "subkind": "headshot", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "8a021ddb-d875-412a-8cce-7518074c124c", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.18, "w": 0.32, "x": 0.16, "y": 0.6 }, "kind": "paragraph", "text": "John Connolly, PhD, Chief Scientific Officer, Parker Institute. Designs and executes PICI's overall research strategy. Associate professor at National University of Singapore and an adjunct associate professor of Immunology at Baylor University. Previously CSO of Tessa Therapeutics.", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "1d680400-e190-47dc-9d44-3975b16e1741", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.18, "w": 0.32, "x": 0.16, "y": 0.39 }, "kind": "paragraph", "text": "Shelley Chu, MD, PhD, Partner, Lightspeed Venture Partners. Two decades of investing and operating experience in the biopharmaceutical industry. Prior operating role at Gilead, leading R&D strategy across all therapeutic areas and business development in immuno-oncology and HBV.", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "3639baaa-f925-4335-94f2-d9c916f5aa8e", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.18, "w": 0.32, "x": 0.645, "y": 0.392 }, "kind": "paragraph", "text": "Sean Parker, Founder and Chairman, Parker Institute. Philanthropist and entrepreneur with a record of launching genre-defining companies and organizations. Co-founder of Napster at age 19 and of Plaxo at 21. Partnered with Mark Zuckerberg to found Facebook and served as Facebook's first president.", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "45018794-39cf-4b7b-8582-bc66aa830201", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.18, "w": 0.32, "x": 0.16, "y": 0.19 }, "kind": "paragraph", "text": "Sean Harper, Managing Director, Westlake Village BioPartners. Former EVP R&D at Amgen managing R&D investment of more than $3.5B annually. Named by Time as one of the 50 most influential people in healthcare in 2018.", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "60d28acc-0029-41a5-af08-54e856e734a1", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.18, "w": 0.32, "x": 0.645, "y": 0.812 }, "kind": "paragraph", "text": "Stefan Scherer, MD, PhD, 3T Chief Executive Officer and Board Member. 20+ years of industry experience (Roche/ Genentech, Novartis, Cellectis, GSK). Cell therapy & biomarker expert.", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "88679e3c-eb97-4111-95f7-ef6c1be803ee", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.18, "w": 0.32, "x": 0.645, "y": 0.192 }, "kind": "paragraph", "text": "Beth Seidenberg, MD, Managing Director, Westlake Village BioPartners. Longtime life sciences investor, founder of WVB and previously general partner at Kleiner Perkins. Incubated and invested in more than 20 biotech ventures since May 2005; Industry leadership roles at leadership roles at Amgen, Bristol-Myers Squibb and Merck.", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "9bb51b87-46a0-4a50-98a9-7598cbb7c335", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.18, "w": 0.32, "x": 0.645, "y": 0.605 }, "kind": "paragraph", "text": "David Piacquad, Former SVP Business Development, Amgen. Over a decade at Amgen responsible for M&A. Licensing, Ventures and Alliance Management. Previously, SVP Business Development & Licensing at Schering-Plough Corporation (sold to Merck) and 20 year career at Johnson & Johnson.", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "e5940e31-ed55-47fc-a798-66eae341bcf9", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.12, "w": 0.85, "x": 0.04, "y": 0.03 }, "kind": "title", "text": "Board of Directors Includes Leaders from Across the Biotechnology Landscape", "attrs": null, "subkind": "headline", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "5ac4b8dc-528f-4541-99cb-544e1ae7775f", "frameworkName": null, "frameworkSlug": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }